Logo
x

Search

Subscribe Now

Worth

Gilead Expands its Oncology Collaboration with Tango for ~$6.3B

Gilead Expands its Oncology Collaboration with Tango for ~$6.3B

  • August 18, 2020
Biogen Signs an Agreement with Denali on LRRK2 Program for Parkinson's Disease Worth ~$2.125B

Biogen Signs an Agreement with Denali on LRRK2 Program for Parkinson's Disease Worth ~$2.125B

  • August 7, 2020
Johnson & Johnson Signs an Agreement with the US Government to Supply 100M Doses of COVID-19 Vaccine Worth ~$1B

Johnson & Johnson Signs an Agreement with the US Government to Supply 100M Doses of COVID-19 Vaccine Worth ~$1B

  • August 6, 2020
Sanofi Signs an Agreement with Kymera to Advance Novel Protein Degrader Therapies Worth Up to $2.1B

Sanofi Signs an Agreement with Kymera to Advance Novel Protein Degrader Therapies Worth Up to $2.1B

  • July 10, 2020
Regeneron Signs an Agreement with BARDA and the US Department of Defense for REGN-COV2 Worth $450M

Regeneron Signs an Agreement with BARDA and the US Department of Defense for REGN-COV2 Worth $450M

  • July 8, 2020
Yuhan Collaborates with GI Innovation for its Allergy Treatment Worth up to $1.2B

Yuhan Collaborates with GI Innovation for its Allergy Treatment Worth up to $1.2B

  • July 2, 2020
Image

Incisive News in 3 Shots.

Contact Us

Our Information

Follow Us

Copyright © 2024 PharmaShots - All Rights Reserved.